-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On Target Laboratories announced today that the U.
Cytoreductive surgery is a common treatment for ovarian cancer, but studies have found that even in patients who received optimal cytoreductive surgery, 40% of patients had measurable findings on imaging tests 30 days after surgery.
Cytalux is a fluorescent imaging agent that binds to the folate receptor, which is overexpressed in most epithelial ovarian cancers
References:
[1] On Target Laboratories Announces FDA Approval of CYTALUX™ (pafolacianine) injection for Identification of Ovarian Cancer During Surgery.
(Original abridged)